In the case of terminal Manα1-2 epitopes (Fig. 5c, d), we for instance only report an absolute decrease in lung cancer and chronic lymphocytic leukemia, after factoring in scale differences between conditions. Here, MAN2C1 is linked to B-cell chronic lymphocytic leukemia.